US Stock MarketDetailed Quotes

GYRE Gyre Therapeutics

Watchlist
  • 10.790
  • -1.210-10.08%
Close Jan 3 16:00 ET
  • 10.790
  • 0.0000.00%
Post 20:01 ET
926.02MMarket Cap-7.39P/E (TTM)

Gyre Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q1)Mar 31, 2022
Total revenue
-20.45%25.49M
-13.99%25.23M
8.99%27.17M
10.91%113.45M
27.15M
32.04M
29.33M
-0.33%24.93M
14.18%102.29M
25.01M
Operating revenue
-20.45%25.49M
-13.99%25.23M
8.99%27.17M
10.91%113.45M
--27.15M
--32.04M
--29.33M
-0.33%24.93M
14.18%102.29M
--25.01M
Cost of revenue
-19.09%958K
-28.51%770K
-12.98%979K
-3.28%4.64M
1.25M
1.18M
1.08M
-6.17%1.13M
19.21%4.79M
1.2M
Gross profit
-20.51%24.53M
-13.44%24.46M
10.03%26.19M
11.61%108.81M
25.9M
30.86M
28.25M
-0.04%23.81M
13.94%97.5M
23.82M
Operating expense
12.18%20.3M
-8.96%21.19M
5.72%18.12M
1.48%89.6M
31.09M
18.09M
23.28M
8.27%17.14M
59.28%88.29M
15.83M
Selling and administrative expenses
16.16%17.52M
-9.50%17.84M
9.88%15.94M
5.88%75.82M
--26.52M
--15.09M
--19.71M
5.43%14.51M
48.16%71.61M
--13.76M
-Selling and marketing expense
-1.64%13.7M
-19.92%14.41M
-1.77%12.54M
12.76%61.16M
--16.46M
--13.93M
--18M
12.72%12.77M
21.47%54.24M
--11.33M
-General and administrative expense
230.42%3.82M
100.12%3.42M
95.40%3.4M
-15.59%14.66M
--10.06M
--1.16M
--1.71M
-28.52%1.74M
371.86%17.37M
--2.43M
Research and development costs
-7.78%2.78M
-5.97%3.36M
-17.19%2.18M
-17.42%13.78M
--4.57M
--3.01M
--3.57M
27.10%2.64M
130.27%16.69M
--2.07M
Operating profit
-66.84%4.23M
-34.42%3.26M
21.11%8.07M
108.77%19.21M
-5.19M
12.76M
4.97M
-16.52%6.66M
-69.46%9.2M
7.98M
Net non-operating interest income expense
84.81%523K
39.44%350K
78.26%328K
43.80%1.04M
326K
283K
251K
1,444.62%184K
179.28%726K
-13.68K
Non-operating interest income
84.81%523K
----
78.26%328K
----
----
--283K
----
--184K
----
----
Non-operating interest expense
----
----
----
----
----
----
----
----
----
--13.68K
Total other finance cost
----
-39.44%-350K
----
-43.80%-1.04M
----
----
---251K
----
---726K
----
Other net income (expense)
55.57%-826K
285.21%2.42M
807.45%4.08M
-18,705.03%-97.22M
-95.42M
-1.86M
629K
-1,441.34%-577K
34.45%-517K
-37.43K
Gain on sale of security
---228K
--2.91M
--4.29M
---9.26M
----
----
----
----
----
----
Special income (charges)
--0
---68K
----
---86.44M
---85.92M
---526K
--0
----
--0
----
-Less:Other special charges
----
----
----
--83.1M
----
----
----
----
----
----
-Gain on sale of business
----
----
----
---2.71M
----
----
----
----
--0
----
-Gain on sale of property,plant,equipment
--0
---68K
----
---628K
---102K
---526K
--0
----
--0
----
Other non- operating income (expenses)
55.14%-598K
-167.09%-422K
64.30%-206K
-193.62%-1.52M
---237K
---1.33M
--629K
-1,441.34%-577K
49.73%-517K
---37.43K
Income before tax
-64.87%3.93M
3.09%6.04M
99.03%12.48M
-917.73%-76.97M
-100.28M
11.19M
5.85M
-20.94%6.27M
-68.21%9.41M
7.93M
Income tax
-70.80%1.07M
-28.17%1.5M
23.95%2.55M
67.03%8.52M
699K
3.68M
2.08M
15.40%2.05M
-17.35%5.1M
1.78M
Net income
-61.97%2.86M
20.37%4.54M
135.59%9.94M
-2,081.46%-85.48M
-100.98M
7.51M
3.77M
-31.45%4.22M
-81.59%4.31M
6.15M
Net income continuous Operations
-61.97%2.86M
20.37%4.54M
135.59%9.94M
-2,081.46%-85.48M
---100.98M
--7.51M
--3.77M
-31.45%4.22M
-81.59%4.31M
--6.15M
Minority interest income
-50.99%1.73M
-47.31%1.01M
21.79%2.4M
270.43%7.45M
29K
3.53M
1.92M
1.97M
2.01M
Net income attributable to the parent company
-71.73%1.12M
90.39%3.53M
235.65%7.53M
-4,137.05%-92.93M
-101.01M
3.98M
1.85M
-63.52%2.24M
-90.18%2.3M
6.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-71.73%1.12M
90.39%3.53M
235.65%7.53M
-4,137.05%-92.93M
-101.01M
3.98M
1.85M
-63.52%2.24M
-90.18%2.3M
6.15M
Basic earnings per share
-80.74%0.01
65.32%0.04
207.16%0.09
-4,790.77%-1.41
-1.3187
0.0519
0.0242
-63.52%0.0293
-90.18%0.0301
0.0803
Diluted earnings per share
-80.74%0.01
-58.67%0.01
2.39%0.03
-4,790.77%-1.41
-1.3187
0.0519
0.0242
-63.52%0.0293
-90.18%0.0301
0.0803
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q1)Mar 31, 2022
Total revenue -20.45%25.49M-13.99%25.23M8.99%27.17M10.91%113.45M27.15M32.04M29.33M-0.33%24.93M14.18%102.29M25.01M
Operating revenue -20.45%25.49M-13.99%25.23M8.99%27.17M10.91%113.45M--27.15M--32.04M--29.33M-0.33%24.93M14.18%102.29M--25.01M
Cost of revenue -19.09%958K-28.51%770K-12.98%979K-3.28%4.64M1.25M1.18M1.08M-6.17%1.13M19.21%4.79M1.2M
Gross profit -20.51%24.53M-13.44%24.46M10.03%26.19M11.61%108.81M25.9M30.86M28.25M-0.04%23.81M13.94%97.5M23.82M
Operating expense 12.18%20.3M-8.96%21.19M5.72%18.12M1.48%89.6M31.09M18.09M23.28M8.27%17.14M59.28%88.29M15.83M
Selling and administrative expenses 16.16%17.52M-9.50%17.84M9.88%15.94M5.88%75.82M--26.52M--15.09M--19.71M5.43%14.51M48.16%71.61M--13.76M
-Selling and marketing expense -1.64%13.7M-19.92%14.41M-1.77%12.54M12.76%61.16M--16.46M--13.93M--18M12.72%12.77M21.47%54.24M--11.33M
-General and administrative expense 230.42%3.82M100.12%3.42M95.40%3.4M-15.59%14.66M--10.06M--1.16M--1.71M-28.52%1.74M371.86%17.37M--2.43M
Research and development costs -7.78%2.78M-5.97%3.36M-17.19%2.18M-17.42%13.78M--4.57M--3.01M--3.57M27.10%2.64M130.27%16.69M--2.07M
Operating profit -66.84%4.23M-34.42%3.26M21.11%8.07M108.77%19.21M-5.19M12.76M4.97M-16.52%6.66M-69.46%9.2M7.98M
Net non-operating interest income expense 84.81%523K39.44%350K78.26%328K43.80%1.04M326K283K251K1,444.62%184K179.28%726K-13.68K
Non-operating interest income 84.81%523K----78.26%328K----------283K------184K--------
Non-operating interest expense --------------------------------------13.68K
Total other finance cost -----39.44%-350K-----43.80%-1.04M-----------251K-------726K----
Other net income (expense) 55.57%-826K285.21%2.42M807.45%4.08M-18,705.03%-97.22M-95.42M-1.86M629K-1,441.34%-577K34.45%-517K-37.43K
Gain on sale of security ---228K--2.91M--4.29M---9.26M------------------------
Special income (charges) --0---68K-------86.44M---85.92M---526K--0------0----
-Less:Other special charges --------------83.1M------------------------
-Gain on sale of business ---------------2.71M------------------0----
-Gain on sale of property,plant,equipment --0---68K-------628K---102K---526K--0------0----
Other non- operating income (expenses) 55.14%-598K-167.09%-422K64.30%-206K-193.62%-1.52M---237K---1.33M--629K-1,441.34%-577K49.73%-517K---37.43K
Income before tax -64.87%3.93M3.09%6.04M99.03%12.48M-917.73%-76.97M-100.28M11.19M5.85M-20.94%6.27M-68.21%9.41M7.93M
Income tax -70.80%1.07M-28.17%1.5M23.95%2.55M67.03%8.52M699K3.68M2.08M15.40%2.05M-17.35%5.1M1.78M
Net income -61.97%2.86M20.37%4.54M135.59%9.94M-2,081.46%-85.48M-100.98M7.51M3.77M-31.45%4.22M-81.59%4.31M6.15M
Net income continuous Operations -61.97%2.86M20.37%4.54M135.59%9.94M-2,081.46%-85.48M---100.98M--7.51M--3.77M-31.45%4.22M-81.59%4.31M--6.15M
Minority interest income -50.99%1.73M-47.31%1.01M21.79%2.4M270.43%7.45M29K3.53M1.92M1.97M2.01M
Net income attributable to the parent company -71.73%1.12M90.39%3.53M235.65%7.53M-4,137.05%-92.93M-101.01M3.98M1.85M-63.52%2.24M-90.18%2.3M6.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -71.73%1.12M90.39%3.53M235.65%7.53M-4,137.05%-92.93M-101.01M3.98M1.85M-63.52%2.24M-90.18%2.3M6.15M
Basic earnings per share -80.74%0.0165.32%0.04207.16%0.09-4,790.77%-1.41-1.31870.05190.0242-63.52%0.0293-90.18%0.03010.0803
Diluted earnings per share -80.74%0.01-58.67%0.012.39%0.03-4,790.77%-1.41-1.31870.05190.0242-63.52%0.0293-90.18%0.03010.0803
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Heat List
US
Overall
Symbol
Price
% Chg

No Data